As of 2024-12-14, the Relative Valuation of Collegium Pharmaceutical Inc (COLL) is 79.51 USD. This relative valuation is based on P/E multiples. With the latest stock price at 30.09 USD, the upside of Collegium Pharmaceutical Inc based on Relative Valuation is 164.3%.
The range of the Relative Valuation is 70.64 - 86.59 USD.
| Range | Selected | |
| Trailing P/E multiples | 27.8x - 31.5x | 30.4x |
| Forward P/E multiples | 27.8x - 30.0x | 29.7x |
| Fair Price | 70.64 - 86.59 | 79.51 |
| Upside | 134.7% - 187.8% | 164.3% |
| Date | P/E |
| 2024-12-10 | 10.98 |
| 2024-12-09 | 11.14 |
| 2024-12-06 | 10.91 |
| 2024-12-05 | 10.87 |
| 2024-12-04 | 11.33 |
| 2024-12-03 | 11.16 |
| 2024-12-02 | 11.40 |
| 2024-11-29 | 11.10 |
| 2024-11-27 | 11.18 |
| 2024-11-26 | 11.35 |
| 2024-11-25 | 11.21 |
| 2024-11-22 | 10.91 |
| 2024-11-21 | 11.07 |
| 2024-11-20 | 10.92 |
| 2024-11-19 | 10.83 |
| 2024-11-18 | 10.64 |
| 2024-11-15 | 10.77 |
| 2024-11-14 | 11.02 |
| 2024-11-13 | 10.99 |
| 2024-11-12 | 11.43 |
| 2024-11-11 | 11.71 |
| 2024-11-08 | 11.71 |
| 2024-11-07 | 12.64 |
| 2024-11-06 | 12.56 |
| 2024-11-05 | 12.17 |
| 2024-11-04 | 11.91 |
| 2024-11-01 | 12.18 |
| 2024-10-31 | 12.43 |
| 2024-10-30 | 12.62 |
| 2024-10-29 | 12.83 |
| 2024-10-28 | 12.79 |
| 2024-10-25 | 12.63 |
| 2024-10-24 | 12.49 |
| 2024-10-23 | 13.06 |
| 2024-10-22 | 13.17 |
| 2024-10-21 | 13.27 |
| 2024-10-18 | 13.99 |
| 2024-10-17 | 14.17 |
| 2024-10-16 | 14.32 |
| 2024-10-15 | 14.03 |
| 2024-10-14 | 13.83 |
| 2024-10-11 | 13.73 |
| 2024-10-10 | 13.34 |
| 2024-10-09 | 13.67 |
| 2024-10-08 | 13.84 |
| 2024-10-07 | 14.49 |
| 2024-10-04 | 15.24 |
| 2024-10-03 | 14.52 |
| 2024-10-02 | 14.27 |
| 2024-10-01 | 14.45 |